| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 84.69B | 84.03B | 79.83B | 81.02B | 81.39B | 85.19B |
| Gross Profit | 34.92B | 34.63B | 31.49B | 30.02B | 30.36B | 31.84B |
| EBITDA | 6.57B | 7.19B | 6.38B | 7.13B | 8.28B | 8.48B |
| Net Income | 3.93B | 4.27B | 3.65B | 4.17B | 5.58B | 5.18B |
Balance Sheet | ||||||
| Total Assets | 54.48B | 56.63B | 53.81B | 53.53B | 49.71B | 50.23B |
| Cash, Cash Equivalents and Short-Term Investments | 6.00B | 8.13B | 7.40B | 10.27B | 7.14B | 8.08B |
| Total Debt | 188.00M | 5.00M | 3.00B | 6.00B | 4.62B | 7.38B |
| Total Liabilities | 17.41B | 20.15B | 20.43B | 21.53B | 19.67B | 23.58B |
| Stockholders Equity | 37.07B | 36.47B | 33.38B | 32.00B | 30.04B | 26.65B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.97B | 3.25B | 5.71B | 3.11B | 978.00M |
| Operating Cash Flow | 0.00 | 6.12B | 3.43B | 5.85B | 3.71B | 3.96B |
| Investing Cash Flow | 0.00 | -3.30B | -332.00M | -414.00M | -1.21B | -3.31B |
| Financing Cash Flow | 0.00 | -4.63B | -5.97B | -2.32B | -3.47B | 2.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥45.49B | 18.73 | ― | 4.27% | 6.15% | -25.28% | |
71 Outperform | ¥85.08B | 5.42 | 6.96% | 2.98% | 1.15% | 86.72% | |
65 Neutral | ¥974.69B | 17.87 | 49.14% | 2.82% | 6.80% | 0.62% | |
63 Neutral | ¥583.67B | 23.34 | 31.11% | ― | 4.83% | 106.29% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥41.99B | 20.81 | 14.53% | 0.21% | 23.01% | 34.28% | |
41 Neutral | ¥1.60T | -12.21 | -21.14% | ― | 11.45% | 42.34% |